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Objectives The aim of this study was to report a series of patients with stress cardiomyopathy precipitated by the intrave-
nous administration of catecholamines and beta-receptor agonists.
Background Stress cardiomyopathy is a syndrome of transient cardiac dysfunction precipitated by intense emotional or physi-
cal stress. Excessive sympathetic stimulation is believed to be central to the pathogenesis of this disorder, but a
causal link has not been convincingly demonstrated.
Methods We observed 9 cases of stress cardiomyopathy precipitated immediately by the intravenous administration of
epinephrine (n  6) or dobutamine (n  3). Patients were evaluated with coronary angiography and with serial
echocardiography, electrocardiography, and cardiac enzymes.
Results The median age was 44 years (interquartile range [IQR]: 30 to 48 years), and 7 (78%) were woman. Troponin-I
was mildly elevated (median 4.07 ng/ml, IQR: 0.47 to 5.63 ng/ml), but none of the patients undergoing angiog-
raphy had obstructive coronary disease. All patients developed corrected QT interval (QTc interval) prolongation
(median QTc interval 504 ms, IQR: 477 to 568 ms) within 24 h of receiving drug. All 3 previously described vari-
ants of left ventricular “ballooning” (apical, midventricular, and basal) were observed. The median ejection frac-
tion on admission was 35% (IQR: 35% to 40%). During follow-up (median 7 days, IQR: 4 to 13 days) there was
recovery of left ventricular systolic function in all patients (median ejection fraction 55%, IQR: 40% to 60%, p 
0.001 vs. admission).
Conclusions Exposure to catecholamines and beta-receptor agonists used routinely during procedures and diagnostic tests
can precipitate all the features of stress cardiomyopathy, including cardiac isoenzyme elevation, QTc interval
prolongation, and rapidly reversible cardiac dysfunction. These observations strongly implicate excessive sympa-
thetic stimulation as central to the pathogenesis of this unique syndrome. (J Am Coll Cardiol 2009;53:
1320–5) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.02.020c
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stress cardiomyopathy (SCM) is a syndrome of profound
et reversible cardiac dysfunction precipitated by acute
motional or physical stress. The cause of SCM is unknown,
ut its frequent association with sudden and intense stress
uggests that the mechanism of transient myocardial dys-
unction might be sympathetically mediated. This is sup-
orted by the observation that plasma catecholamine levels
re markedly elevated in acute SCM compared with acute
yocardial infarction (1). Case reports have also described
he onset of SCM in patients with catecholamine-secreting
umors (2). Endomyocardial biopsy samples from patients
ith SCM have demonstrated contraction band necrosis, a
nique form of myocyte injury observed in clinical states of
rom the *Division of Cardiology, Department of Medicine, Johns Hopkins
niversity School of Medicine, Baltimore, Maryland; and the †Division of Cardiol-
gy, Tufts Medical Center, Boston, Massachusetts.a
Manuscript received December 8, 2008; revised manuscript received February 19,
009, accepted February 24, 2009.atecholamine excess (1). Despite these reports, a causal link
etween catecholamine exposure and SCM has not been
onvincingly demonstrated. In this observational case series,
e report the clinical characteristics of 9 patients who
eveloped SCM immediately after the intravenous admin-
stration of catecholamines and beta-receptor agonists.
ethods
etween 2001 and 2008, 143 patients were diagnosed with
CM at our institution. Nine of these patients (6.3%) devel-
ped SCM immediately after the intravenous administration
f epinephrine or dobutamine. SCM was diagnosed on the
asis of characteristic patterns of left ventricular (LV) dysfunc-
ion extending beyond a single epicardial coronary artery
erritory (“ventricular ballooning”). Specific patterns of regional
all motion included apical and midventricular akinesis with
paring of the base (apical ballooning variant); midventricular
kinesis with preserved contraction of the apex and base
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asal akinesis with normal apical contractility (basal ballooning
ariant) (1,3,4). Additional clinical evidence supporting the
iagnosis of SCM included minimal elevation in cardiac
soenzymes, despite the presence of large regions of focal
kinesis, the evolution of electrocardiographic (ECG) abnor-
alities that frequently included deep diffuse T-wave inversion
nd corrected QT interval (QTc interval) prolongation, the
bsence of obstructive coronary artery disease by angiography,
nd the rapid improvement in LV systolic function (1).
Patients were evaluated in the acute setting with serial
CGs, cardiac isoenzymes, and transthoracic echocardiog-
aphy. Seven patients underwent coronary angiography at
he discretion of the treating physician. Cardiac catheter-
zation was deferred in 2 young patients (Patients #5 and
8), because coronary artery disease was deemed highly
nlikely. All patients had follow-up echocardiography
ithin 2 weeks.
Continuous variables are presented as median and inter-
uartile range (IQR). Wilcoxon signed rank test was used
o compare ejection fractions at various time intervals
fter onset of SCM. A 2-tailed p  0.05 was considered
tatistically significant. The study was approved by the
linical Features on Admission of Patients With Stress Cardiomyop
Table 1 Clinical Features on Admission of Patients With Stress
Patient #
Age
(yrs) Sex Drug Event
HR
(beats/min)
M
(m
1 46 M Dobutamine Dobutamine
echo
92
2 51 F Dobutamine Dobutamine
echo
59
3 41 F Dobutamine Dobutamine
echo
63
4 30 F Epinephrine Suicide
attempt
88
5 24 F Epinephrine Liposuction 100
6 48 F Epinephrine Facelift 85
7 44 F Epinephrine Keloid
repair
136
8 20 M Epinephrine Colonoscopy 100
9 54 F Epinephrine Vasovagal
syncope
100
F  ejection fraction by echocardiography; HR  heart rate; IABP  intra-aortic balloon pump; M
linical Characteristics of Patients Developing Stress Cardiomyopa
Table 2 Clinical Characteristics of Patients Developing Stress
Patient # Indication
Dobutamine
(g/kg/min)
HR (beats/min) BP
Baseline Peak Baseline
1 Pre-operative
evaluation
40 83 146 86/54
2 Atypical
chest pain
40 59 125 136/72
3 Atypical
chest pain
30 59 126 112/72K  akinesis; BP  blood pressure; ECG  electrocardiogram; EF  ejection fraction; HK  hypokine
T-segment elevation; WMA  wall motion abnormality.nstitutional review board of Johns
opkins University School of
edicine.
esults
he median age of the patients
as 44 years (IQR: 30 to 48 years),
nd 7 patients (78%) were women
Table 1). Three patients were
aucasian, 4 were African Amer-
can, 1 was Vietnamese, and 1 was
rom Bermuda. Six patients had
o coronary risk factors, 2 patients
ad a history of tobacco use, and 1
atient had hypertension and diabetes mellitus.
Patients #1, #2, and #3 experienced the onset of symp-
oms while receiving standard doses of intravenous dobut-
mine (30 to 40 g/kg/min) during stress echocardiography
Table 2, Fig. 1). Patient #4 was a health care provider who
ttempted suicide by intravenously injecting multiple vials
f epinephrine (estimated dose 40 mg). Patient #5 inadver-
ently received 1 mg of intravenous epinephrine during
iomyopathy
Killip
Class
Peak Tn-I
(ng/ml)
Max QTc
(ms)
Hemodynamic
Support
Ballooning
Pattern
EF
(%)
1 0.17 475 None Apical 35
2 0.46 652 IABP Midventricular 35
1 4.1 477 None Midventricular 35
4 0.47 499 Dopamine Apical 15
3 3.2 540 Dopamine Apical 15
3 5.6 568 None Basal 35
3 12 471 Norepinephrine Basal 40
3 7.4 607 None Basal 40
1 4.4 504 None Basal 40
mean arterial pressure; Max QTc  maximum corrected QT interval; Tn-I  troponin-I.
uring Dobutamine Stress Echocardiography
omyopathy During Dobutamine Stress Echocardiography
g) ECG Findings
Echocardiographic
Findings
Peak Baseline Peak Baseline Peak
48/90 Normal Nonspecific
ST-segment
changes
EF 60%,
no WMA
EF 35%; anterior
and apical AK
94/100 LBBB LBBB; 1 mm
inferolateral STD
EF 55%,
no WMA
EF 30%; septal
and apical AK
73/97 Nonspecific
T-wave
changes
1mm inferolateral
STE
EF 55%,
no WMA
EF 35%; anterior
and apical HK
Abbreviations
and Acronyms
ECG  electrocardiogram/
electrocardiographic
IABP  intra-aortic balloon
pump
IQR  interquartile range
LV  left
ventricle/ventricular
QTc interval  corrected
QT interval
SCM  stress
cardiomyopathyathy
Card
AP
m Hg)
55
60
77
55
55
69
67
57
121thy D
Cardi
(mm H
1
1
1sis; HR  heart rate; LBBB  left bundle branch block; STD  ST-segment depression; STE 
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Intravenous Catecholamines and Stress Cardiomyopathy April 14, 2009:1320–5utpatient liposuction, and Patient #6 was given 1 mg of
ntravenous epinephrine during cosmetic facial surgery.
Figure 1 Acute Onset of Stress Cardiomyopathy
During Dobutamine Stress Echocardiography
Standard transthoracic views obtained during a dobutamine stress echocardiogram
at baseline (A), peak dobutamine infusion (B), and post-dobutamine infusion (C)
in Patient #1. The views demonstrated in all 3 panels include parasternal long-axis
(top left), short-axis (top right), apical 4-chamber (bottom left), and apical
2-chamber (bottom right). Baseline images (A) show normal left ventricular sys-
tolic function. At peak dobutamine infusion (B), there is severe mid-ventricular and
apical hypokinesis that persists into recovery (C). Cardiac catheterization 2 days
later revealed normal coronary arteries and recovery of left ventricular systolic func-
tion. Also see accompanying Online Videos 1, 2, and 3.atient #7 was administered an unknown dose of epineph- rine directly into a superficial vein during repair of a keloid
car. Patient #8 was mistakenly treated with undiluted
pinephrine (1:1,000 dilution) injected into a bleeding rectal
ein during colonoscopy (estimated dose approximately 5
g). Patient #9 was an inpatient who was incorrectly given
mg of intravenous epinephrine after an episode of vaso-
agal syncope.
All patients developed chest pain after drug administra-
ion, and 6 patients (67%) developed symptomatic heart
ailure with a median Killip class of 3 (IQR: 1 to 3). One
atient was intubated for pulmonary edema, 1 patient
equired an intra-aortic balloon pump, and 3 patients
equired vasopressor support (Table 1). There were no
ustained arrhythmias or in-hospital deaths.
The presenting ECG showed ST-segment depression in
patients, 1 in inferior and lateral leads and the other
iffusely. One patient had diffuse precordial ST-segment
levation at the time of admission. T-wave inversions were
resent on admission in 3 patients. One patient had
waves in leads V1 to V3 on presentation that resolved
uring recovery. Within 24 h of receiving drug, all 9
atients developed prolongation of the QTc interval (me-
ian QTc interval 504 ms, IQR: 477 to 568 ms), and 7 of
he 9 patients developed diffuse T-wave abnormalities.
eep inverted T waves evolved in patients with apical
allooning, whereas broad upright T waves were observed in
atients with the basal ballooning variant. Patients with
idventricular ballooning were more likely to have nonspe-
ific T-wave abnormalities (Fig. 2).
Despite severe LV dysfunction at the time of admis-
ion, cardiac enzymes were only mildly elevated with a
eak creatinine phosphokinase of 319 IU/l (IQR: 175 to
17 IU/l) and a peak MB of 24 ng/ml (IQR: 17 to 33
g/ml). Peak troponin I was 4.2 ng/ml (IQR: 0.47 to 6.5
g/ml) (Table 1).
All 7 patients undergoing coronary angiography had
ormal coronary arteries. The median interval between drug
dministration and left heart catheterization was 1 day
IQR: 1 to 2 days). Left ventriculography was performed in
patients with a median ejection fraction of 35% (IQR:
0% to 35%) and median LV end-diastolic pressure of 24
m Hg (IQR: 18 to 25 mm Hg).
All patients underwent echocardiography at the time of
dmission, and all 3 LV ballooning variants of SCM were
bserved (Fig. 3). Apical ballooning was observed in 3
atients (33%), midventricular ballooning occurred after
obutamine administration in 2 patients (22%), and 4
atients (44%) developed basal ballooning after receiving
pinephrine. The median ejection fraction at the time of
dmission was 35% (IQR: 35% to 40%). Right ventricular
unction was normal in all patients except Patient #4, who
ad moderate global right ventricular dysfunction. Repeat
chocardiography performed during follow-up (median 7
ays, IQR: 4 to 13 days) demonstrated near complete
ecovery of LV systolic function in all patients, with a
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April 14, 2009:1320–5 Intravenous Catecholamines and Stress Cardiomyopathyedian ejection fraction of 55% (IQR: 40% to 60%, p 
.001 vs. admission).
iscussion
he current report highlights several important observations.
irst, all of the characteristic clinical features of SCM were
recipitated acutely by the direct infusion of intravenous
atecholamines. These features included mild cardiac enzyme
levation in the absence of obstructive coronary disease, a
rolonged QTc interval and diffuse T-wave abnormalities on
CG, ventricular ballooning, and rapid recovery of LV systolic
unction. Second, SCM occurred after routine diagnostic tests
nd outpatient procedures and was precipitated not only by
upratherapeutic doses of epinephrine but also by standard
oses of dobutamine typically used in clinical practice. Finally,
he administration of intravenous catecholamines and beta-
eceptor agonists resulted in all 3 ventricular ballooning pat-
Figure 2 Electrocardiograms Associated With the 3 Ballooning
T-wave inversion, Q waves, and corrected QT interval (QTc interval) prolongation we
the midventricular variant (B). Broad upright T waves and QTc interval prolongation
within 24 to 48 h of drug administration.erns associated with SCM. eConsiderable evidence suggests that enhanced sympa-
hetic activity might play a pathogenic role in the transient
yocardial dysfunction seen with SCM. Plasma catechol-
mine and neuropeptide levels in patients with SCM
nduced by acute emotional stress are markedly elevated
ompared with patients with myocardial infarction (1).
23I-metaiodobenzyl-guanidine imaging in patients with
pical ballooning reveals impaired sympathetic innervation
n the dysfunctional apex, despite normal perfusion (5).
ase reports of SCM due to catecholamine-secreting tu-
ors (2) and acute brain injury (6) further support the
otion of sympathetically mediated myocardial stunning.
he current report further implicates enhanced sympathetic
timulation in the pathogenesis of this syndrome by dem-
nstrating a causal link between beta-adrenergic stimulation
nd the development of SCM.
The precise mechanism of catecholamine-mediated
yocardial stunning in SCM remains unknown. Isch-
nts of Stress Cardiomyopathy After Drug Administration
n with the apical variant (A). Nonspecific T-wave abnormalities were seen with
characteristic of the basal variant (C). These electrocardiogram patterns evolvedVaria
re see
weremia due to epicardial spasm seems unlikely and would
n
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Intravenous Catecholamines and Stress Cardiomyopathy April 14, 2009:1320–5ot readily explain the various ballooning patterns seen
ith this syndrome. Decreased coronary flow velocity and
igher thrombolysis in myocardial infarction frame
ounts in patients with SCM suggest the possibility of
atecholamine-mediated microvascular dysfunction (7),
ut these findings could be secondary effects of myocar-
ial stunning rather than the primary cause. An alterna-
ive explanation is a direct toxic effect of catecholamines
n cardiac myocytes. Catecholamines decrease myocyte
iability through cyclic adenosine monophosphate-
ediated calcium overload, resulting in contraction band
ecrosis, a histologic pattern of myocyte injury observed
n SCM (1) and other hyperadrenergic disease states (8).
n an experimental animal model, acute catecholamine
verload resulted in myocyte apoptosis and necrosis
ediated by hyperphosphorylation of the ryanodine
eceptor-2 (9). In rodent models of SCM, myocardial
njury was prevented by treatment with alpha and beta-
drenergic receptor antagonists (10). The mechanism and
eterminants of the various ventricular ballooning pat-
erns observed in SCM are also unknown. In the canine
eart, the apical myocardium has a greater density of
eta-adrenergic receptors and an increased response to
ympathetic stimulation compared with the base (11).
his observation has been used to explain the apical
Figure 3 Ventricular Ballooning Variants in Stress Cardiomyopa
Two-dimensional echocardiogram of a patient with the apical ballooning variant (le
with the midventricular variant (middle) and the basal ballooning variant (right). Dallooning pattern, although a similar gradient in recep- gor density has not been demonstrated in humans. In fact,
he basal portion of the human LV possesses the highest
oncentration of sympathetic nerve endings (12).
hereas neural control of the human heart remains
ncompletely characterized, it is likely that the different
allooning patterns seen with SCM result from the
omplex interplay between sympathetic innervation,
eta-receptor density and function, and catecholamine
ensitivity.
Whereas 2 patients in this series (Patients #4 and #8)
learly received an overdose of epinephrine, the majority of
atients developed SCM after exposure to drug doses
outinely used in clinical practice. This suggests there might
e individual susceptibility to catecholamine-mediated
yocardial dysfunction. The strong female preponderance
n this series and in other published reports of SCM (1,13)
ighlights the potentially important influence that sex
ormones might have on the cardiac response to emotional
nd physiologic stressors (14). Genetic variability in myo-
ardial adrenergic signaling or other signal transduction
athways might also influence susceptibility to SCM. Tro-
onin elevation and myocardial dysfunction after subarach-
oid hemorrhage have been associated with certain alpha
nd beta-adrenergic receptor polymorphisms (15). Similar
fter Drug Administration
ntrast ventriculography of patients
(top) and systole (bottom) in all panels.thy A
ft). Co
iastoleenetic factors might play an important pathogenic role in
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atecholamine infusion.
In summary, this observational series provides compel-
ing evidence that exaggerated sympathetic stimulation is
ufficient to precipitate the syndrome of SCM in suscep-
ible individuals. Although many questions regarding
CM remain unanswered, this report offers unique in-
ight into the pathogenesis of this increasingly recognized
linical syndrome.
eprint requests and correspondence: Dr. Ilan S. Wittstein,
ivision of Cardiology, Johns Hopkins Hospital, Carnegie 568,
00 North Wolfe Street, Baltimore, Maryland 21287. E-mail:
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APPENDIX
or supplementary videos and their legends, please see the online version
f this article.
